Abstract
A previous study, with relatively small number of patients, showed that prior Mycobacterium tuberculosis (TB) may precipitate SLE in patients from endemic areas. The purpose of the study was to investigate the relationship between prior TB infection and systemic lupus erythematosus (SLE) from the National Health Insurance Research Database (NHIRD) in Taiwan. Cases of SLE and TB were identified from the NHIRD with corresponding ICD-9 codes 710.0 and 011-018, respectively, from January 2000 to December 2008. A total of 2,721 cases of SLE and 10,823 control subjects were included in data analysis. The average annual incidence rate was 8.1 per 100,000. The annual incidence rates of SLE decreased from 6.38 per 100,000 to 2.55 per 100,000 during 2000–2008. Compared with the control subjects, SLE patients were more likely to be white collar workers (P = 0.0005), reside in highly urbanized areas (P = 0.0140), and have higher incomes (P = 0.0088). TB was much more prevalent in SLE patients than in the control subjects (1.8 vs. 0.9%, P < 0.001). The mean time interval between diagnosis of TB and SLE was 45.58 ± 39.0 months. On multivariate analysis, TB was the greatest potential risk factor for precipitating SLE (OR = 2.11, 95% CI = 1.49–3.00). In addition, patients with co-existing TB and DM had a higher risk of SLE than the control group (OR = 3.91, 95% CI 1.84–8.31). In conclusion, this study suggests that there is an increased risk of precipitating SLE among patients with TB in Taiwan from a nationwide health insurance research dataset. Mycobacterial infections could trigger autoimmune diseases in experimental studies. Furthermore, a study with relatively small number of patients revealed that prior TB may precipitate SLE in patients from endemic areas. There is an increased risk of precipitating SLE among patients with TB in Taiwan from a nationwide health insurance research dataset during a 9-year period.
Similar content being viewed by others
References
Bertsias GK, Salmon JE, Boumpas DT (2010) Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann Rheum Dis 69:1603–1611
Pavlovic M, Kats A, Cavallo M et al (2010) Clinical and molecular evidence for association of SLE with parvovirus B19. Lupus 19:783–792
Svensson E, Millet J, Lindqvist A et al (2010) Impact of immigration on tuberculosis epidemiology in a low burden country. Clin Microbiol Infect doi:10.1111/j.1469-0691.2010.03358.x
Furlow B (2010) Tuberculosis: a review and update. Radiol Technol 82:33–52
Hehenkamp A, Hargreaves S (2003) Tuberculosis treatment in complex emergencies: South Sudan. Lancet 362(Suppl):s30–s31
Frieden TR, Sterling TR, Munsiff SS et al (2003) Tuberculosis. Lancet 362:887–899
Corbett EL, Watt CJ, Walker N et al (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163:1009–1021
Holoshitz J, Matitiau A, Cohen IR (1984) Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J Clin Invest 73:211–215
van Eden W, Holoshitz J, Nevo Z et al (1985) Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci USA 82:5117–5120
Shoenfeld Y, Schwartz RS (1984) Immunologic and genetic factors in autoimmune diseases. N Engl J Med 311:1019–1029
Sayarlioglu M, Inanc M, Kamali S et al (2004) Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization. Lupus 13:274–278
Yun JE, Lee SW, Kim TH et al (2002) The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea. Clin Exp Rheumatol 20:127–132
Ghosh K, Patwardhan M, Pradhan V (2009) Mycobacterium tuberculosis infection precipitates SLE in patients from endemic areas. Rheumatol Int 29:1047–1050
Hsueh PR, Liu YC, So J et al (2006) Mycobacterium tuberculosis in Taiwan. J Infect 52:77–85
Naleway AL, Davis ME, Greenlee RT et al (2005) Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus 14:862–866
Nightingale AL, Farmer RD, de Vries CS (2006) Incidence of clinically diagnosed systemic lupus erythematosus 1992–1998 using the UK General Practice Research Database. Pharmacoepidemiol Drug Saf 15:656–661
Iseki K, Miyasato F, Oura T et al (1994) An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis 23:547–554
Chiu YM, Lai CH (2010) Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan. Lupus 19:1250–1255
Huang JL, Yao TC, See LC (2004) Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan. Clin Exp Rheumatol 22:776–780
Wang TF, Lin HC (2008) Relationship between caseload volume and outcome for systemic lupus erythematosus treatment: the experience of Taiwan. J Rheumatol 35:1795–1800
Lindqvist KJ, Coleman RE, Osterland CK (1970) Autoantibodies in chronic pulmonary tuberculosis. J Chronic Dis 22:717–725
Singer JM, Plotz CM, Perlata FM et al (1962) The presence of anti-gamma globulin factors in sera of patients with active pulmonary tuberculosis. Ann Intern Med 56:545–552
Alarcon-Segovia D, Fishbein E (1975) Patterns of antinuclear antibodies and lupus-activating drugs. J Rheumatol 2:167–171
Sarzi-Puttini P, Atzeni F, Capsoni F et al (2005) Drug-induced lupus erythematosus. Autoimmunity 38:507–518
Shoenfeld Y, Vilner Y, Coates AR et al (1986) Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol 66:255–261
Correa PA, Gomez LM, Cadena J et al (2005) Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 32:219–224
Acknowledgments
This study was supported by the National Sciences Council, Executive Yuan (Grant Numbers NSC 95-2625-Z-039-002, NSC 96-2625-Z-039-003, NSC 97-2625-M-039-003, NSC 98-2621-M-039-001), China Medical University Hospital (Grant Number 1MS1) and Taiwan Department of Health Clinical Trial and Research Center for Excellence (Grant Number DOH99-TD-B-111-004).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Y.-C. Lin and S.-J. Liang contributed equally.
Rights and permissions
About this article
Cite this article
Lin, YC., Liang, SJ., Liu, YH. et al. Tuberculosis as a risk factor for systemic lupus erythematosus: results of a nationwide study in Taiwan. Rheumatol Int 32, 1669–1673 (2012). https://doi.org/10.1007/s00296-011-1847-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-1847-5